Person—glycosylated haemoglobin level, code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type:![]() | Data Element |
---|---|
Short name:![]() | Glycosylated haemoglobin level |
Synonymous names:![]() | HbA1c level |
METEOR identifier:![]() | 589601 |
Registration status:![]() |
|
Definition:![]() | A person's glycosylated haemoglobin (HbA1c) level, as represented by a code. |
Data Element Concept:![]() | Person—glycosylated haemoglobin level |
Value domain attributes | |||||||||||
Representational attributes | |||||||||||
Representation class:![]() | Code | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Data type:![]() | Number | ||||||||||
Format:![]() | N | ||||||||||
Permissible values:![]() |
| ||||||||||
Source and reference attributes | |||||||||||
Submitting organisation:![]() | Australian Institute of Health and Welfare (AIHW) | ||||||||||
Data element attributes | |||||||||||
Collection and usage attributes | |||||||||||
Guide for use:![]() | Prior to 2013, glycosylated haemoglobin levels were usually recorded as a percentage in Australia. However, the International HbA1c Consensus Committee recommends that the best way to record glycosylated haemoglobin levels is in mmol/mol. This recommendation was supported by the Australasian Association of Clinical Biochemists, the Royal College of Pathologists of Australasia, the Australian Diabetes Educators Association, and the Australian Diabetes Society. Following this, HbA1c results are now being recorded in two ways in clinical systems; as a percentage and as mmol/mol. HbA1c results should be reported for all clients, regardless of the manner in which their HbA1c is recorded. | ||||||||||
Comments:![]() | Glycosylated haemoglobin (HbA1c) is an index of average blood glucose level for the previous 2 to 3 months and is used to monitor blood sugar control in people with diabetes. | ||||||||||
Source and reference attributes | |||||||||||
Submitting organisation:![]() | Australian Institute of Health and Welfare (AIHW) | ||||||||||
Relational attributes | |||||||||||
Related metadata references:![]() | Supersedes Person—glycosylated haemoglobin level, code N
| ||||||||||
Implementation in Data Set Specifications:![]() | Health, Superseded 13/03/2015 Indigenous, Superseded 13/03/2015 Implementation start date: 01/07/2014 Implementation end date: 30/06/2015 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care DSS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months. Health, Superseded 25/01/2018 Indigenous, Superseded 27/02/2018 Implementation start date: 01/07/2015 Implementation end date: 30/06/2017 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care DSS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months. Health, Superseded 06/09/2018 Indigenous, Superseded 22/10/2018 Implementation start date: 01/07/2017 Implementation end date: 30/06/2018 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care NBEDS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months. Health, Superseded 12/12/2018 Indigenous, Superseded 02/04/2019 Implementation start date: 01/07/2018 Implementation end date: 30/06/2019 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care NBEDS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months. Health, Superseded 16/01/2020 Indigenous, Superseded 14/07/2021 Implementation start date: 01/07/2019 Implementation end date: 30/06/2020 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care NBEDS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months. Health, Retired 13/10/2021 Implementation start date: 01/07/2020 Implementation end date: 30/06/2021 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care NBEDS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months. Indigenous, Superseded 03/07/2022 Implementation start date: 01/07/2020 Implementation end date: 31/12/2020 Conditional obligation: Reporting against this data element is conditional on a person having both:
DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW. Indigenous, Superseded 12/06/2023 Implementation start date: 01/07/2021 Implementation end date: 31/12/2021 Conditional obligation: Reporting against this data element is conditional on a person having both:
DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW. Indigenous, Standard 27/08/2023 Implementation start date: 01/07/2022 Implementation end date: 31/12/2022 Conditional obligation: Reporting against this data element is conditional on a person having both:
DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW. Indigenous, Superseded 06/11/2022 Implementation start date: 01/01/2021 Implementation end date: 30/06/2021 Conditional obligation: Reporting against this data element is conditional on a person having both:
DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW. Indigenous, Superseded 27/08/2023 Implementation start date: 01/01/2022 Implementation end date: 30/06/2022 Conditional obligation: Reporting against this data element is conditional on a person having both:
DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW. | ||||||||||
Implementation in Indicators:![]() |
Used as Numerator
Indigenous primary health care: PI06a-Number of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2014
Indigenous primary health care: PI06a-Number of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2015
Indigenous primary health care: PI06a-Number of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2015-2017
Indigenous primary health care: PI06a-Number of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2015-2017
Indigenous primary health care: PI06a-Number of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2018-2019
Indigenous primary health care: PI06a-Number of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, June 2020
Indigenous primary health care: PI06b-Proportion of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2014
Indigenous primary health care: PI06b-Proportion of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2015
Indigenous primary health care: PI06b-Proportion of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2015-2017
Indigenous primary health care: PI06b-Proportion of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2015-2017
Indigenous primary health care: PI06b-Proportion of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, 2018-2019
Indigenous primary health care: PI06b-Proportion of regular clients with Type II diabetes whose HbA1c measurement result was within a specified level, June 2020
Indigenous-specific primary health care: PI06a-Number of Indigenous regular clients with type 2 diabetes who have an HbA1c measurement result within a specified level, December 2020
Indigenous-specific primary health care: PI06a-Number of Indigenous regular clients with type 2 diabetes who have an HbA1c measurement result within a specified level, December 2021
Indigenous-specific primary health care: PI06a-Number of Indigenous regular clients with type 2 diabetes who have an HbA1c measurement result within a specified level, December 2022
Indigenous-specific primary health care: PI06a-Number of Indigenous regular clients with type 2 diabetes who have an HbA1c measurement result within a specified level, June 2021
Indigenous-specific primary health care: PI06a-Number of Indigenous regular clients with type 2 diabetes who have an HbA1c measurement result within a specified level, June 2022
Indigenous-specific primary health care: PI06b-Proportion of Indigenous regular clients with type 2 diabetes who have an HbA1c measurement result within a specified level, December 2020
Indigenous-specific primary health care: PI06b-Proportion of Indigenous regular clients with type 2 diabetes who have an HbA1c measurement result within a specified level, December 2021
Indigenous-specific primary health care: PI06b-Proportion of Indigenous regular clients with type 2 diabetes who have an HbA1c measurement result within a specified level, December 2022
|